Why Investors Need to Take Advantage of These 2 Consumer Discretionary Stocks Now

Ahead of upcoming reports, Marriott (MAR) has a Zacks #2 (Buy) rank and +1.56% Earnings ESP, based on a $2.91 Most Accurate Estimate versus $2.87 consensus, with results scheduled for November 2, 2026. Crocs (CROX), also ranked #2 (Buy), has a +0.60% ESP from a $3.33 estimate versus $3.31 consensus ahead of its October 29, 2026 report; these metrics indicate potential for, but do not guarantee, earnings beats. Zacks says the positive-ESP/#3-or-better screen produced positive surprises 70% of the time and average annual returns of 28.3% in its 10-year backtest.

Analysis

The signal here is event-risk information, not evidence of improving underlying demand. Small positive estimate gaps can raise the probability of an EPS beat without implying positive post-report returns: positioning and the quality of the beat matter more than the headline surprise. In particular, earnings supported by cost timing or buybacks would be less durable than evidence of stronger end demand.

Near term, both names face binary report risk; the article provides no valuation, positioning, or estimate-revision history to establish attractive risk/reward. For Marriott, focus on RevPAR, fee growth, and forward booking commentary: a beat without firmer operating indicators may not sustain a rerating. For Crocs, assess brand-level demand, promotional intensity, and inventory/channel commentary, including whether weakness in one brand is being offset by the other. These measures can reveal a demand or margin deterioration that a consolidated EPS beat obscures.

Over 1–3 months, guidance revisions and follow-through in operating metrics matter more than the reported quarter. Over 6–18 months, persistent travel demand would support hotel fee economics, while sustained apparel discounting or inventory pressure would weigh on Crocs’ earnings quality. The contrarian point: the article’s backtest statistic is not a stock-specific edge; even a reported beat can disappoint if forward expectations rise faster than results. There is no basis here for a directional pair trade or a conviction pre-earnings position.

Key Decisions for Investors

• Do not buy either stock solely on the reported Earnings ESP. The article supplies no evidence on estimate breadth, revisions, valuation, or positioning; treat the figures as a low-conviction catalyst flag.
• For MAR, stay on watch through the November 2 report; consider a long only if operating commentary (especially RevPAR and forward demand) confirms the EPS outcome and guidance is maintained or raised. A beat with weakening operating indicators falsifies the bullish setup.
• For CROX, avoid initiating ahead of the October 29 report; reassess after brand-level demand, promotional intensity, and inventory commentary. Broad discounting or weaker forward guidance would outweigh a small consensus beat.
• If already long either name, size exposure for overnight gap risk and define an exit around a guidance cut or clear deterioration in the relevant operating metrics; no price-based stop can be set from the information provided.